Letzter Komplett-Check
Nie überprüft
Teams off. / Teams in TC17
20/0
Spieler
318
Legionäre
45.0%
Super League 2 22/23
| Pos. | Team | Spieler | |
|---|---|---|---|
| 1 |  |
Athens Kallithea | 29 |
| 2 |  |
PAS Lamia 1964 | 24 |
| 3 |  |
Iraklis Thessaloniki | 47 |
| 4 |  |
PS Kalamata | 30 |
| 5 |  |
Panionios Athen | 21 |
| 6 |  |
PAS Giannina | 22 |
| 7 |  |
Kampaniakos | 1 |
| 8 |  |
AO Egaleo | 7 |
| 9 |  |
GS Ilioupolis | 2 |
| 10 |  |
Makedonikos Neapolis | 10 |
| 11 |  |
PAOK Thessaloniki II | 2 |
| 12 |  |
Niki Volou | 31 |
| 13 |  |
AO Kavala | 16 |
| 14 |  |
PAE Chania | 33 |
| 15 |  |
Ionikos Nikeas | 23 |
| 16 |  |
Nestos Chrysoupolis | 2 |
| 17 |  |
Anagennisi Karditsas | 13 |
| 18 |  |
Ellas Syrou | 0 |
| 19 | |
Gymnastikos Syllogos Marko Markopoulou | 0 |
| 20 |  |
Olympiakos Piräus II | 5 |
Ligen-Vergleich
| Platz | Nat. | Liga | Mw.-Schnitt |
|---|---|---|---|
| 104 |  |
2. Liga Südkorea | 219.843 € |
| 105 |  |
1. Liga Panama | 219.792 € |
| 106 |  |
2. Liga Griechenland | 217.453 € |
| 107 |  |
1. Liga Bosnien-Herzegowina | 210.887 € |
| 108 |  |
4. Liga Italien E | 209.226 € |
Spieler-Statistik
Top-Spieler
| Name | Alt | St. | Tal. | Team | |
|---|---|---|---|---|---|
  |
Richard Jensen | 29 J. | 15.6 | PIO |
|
  |
Gael Acosta | 33 J. | 15.9 | |
|
  |
Sebá | 33 J. | 15.7 | NIK |
|
  |
A. Moreira | 30 J. | 15.2 | |
|
 |
S. Athanasiadis | 36 J. | 15.6 | |
|
  |
Alejandro Arribas | 36 J. | 15.6 | |
|
 |
Álvaro Jiménez | 30 J. | 15.2 | IRA |
|
  |
Migouel Alfarela | 27 J. | 15.2 | GSK |
|
  |
Eugenio Isnaldo | 31 J. | 15.3 | IRA |
|
 |
Nikolaos Zouglis | 21 J. | 15.1 | |
Top-Talente
| Name | Alt | St. | Tal. | Team | |
|---|---|---|---|---|---|
|
Nikolaos Zouglis | 21 J. | 15.1 | |
|
 |
Dimitrios Metaxas | 21 J. | 14.7 | GSK |
|
  |
Bilal Mazhar | 21 J. | 14.5 | LAM |
|
 |
C. Ioannidis | 21 J. | 14.4 | NIK |
|
  |
N. Sikharulashvili | 21 J. | 14.4 | |
|
  |
A. Sapovalov | 22 J. | 14.5 | |
|
 |
I. Simantirakis | 19 J. | 14.1 | PAS |
|
 |
Leonid Mina | 21 J. | 14.3 | PAS |
|
 |
K. Tanoulis | 20 J. | 14.2 | |
|
 |
Juan Cantillo | 22 J. | 14.4 | GSK |
